Antioxidant Activity of 50 Traditional Chinese Medicinal Materials Varies with Total Phenolics

This study was designed to determine the total phenolic content of 50 herbs and to examine their antioxidant potential. In the sample preparation, 60% ethanol was chosen as the extraction solvent for the subsequent experiments. Folin-Cicolteau phenol reagent and a colorimetric method were used to determine the total phenolic content of the selected herbs. The result showed that total phenolic content of those herbs ranged from 2 to 185 mg/g. In antioxidant assay, the ferric reducing/antioxidant power (FRAP) values ranged from 2 to 134 mg GAE/g;the IC50 values of DPPH?·, ·OH and ?scavenging were in the range of 0.06 - 5.50 mg/mL, 0.017 - 0.636 mg/mL and 0.050 - 0.681 mg/mL respectively. Flos caryophylli was the exceptant in the ?scavenging assay because there was no linear relation between the concentration and the scavenging percentage. Compared to gallic acid, ascorbic acid and butylated hydroxytoluene (BHT) in antioxidant assay as positive control, the most potential antioxidant herbs were Cacumen platycladi, Radix et Rhizoma rhei, Rhizoma rhodiolae crenulatae, and Rhizoma sanguisorbae with considerable content of phenolics. Especially, a positive and significant correlation was found between the total phenolic content and FRAP value or DPPH· scavenging percentage.

Reason Analysis and Risk Prevention of Soaring Price of Traditional Chinese Medicinal Materials

In recent years,the price of traditional Chinese medicinal materials soars continuously,and the resulting price risk increasingly looms large,which has critically affected midstream and downstream industries and peoples' demand for drug,and imperiled healthy and orderly development of traditional Chinese medicinal industries.Based on the status quo of continuous skyrocketing price of traditional Chinese medicinal materials at present,we winkle out the root cause of soaring price as follows:the supply and demand lose balance;the production costs hike up;there are other factors responsible for soaring price.This paper further analyses the impact of sharp increase in price of traditional Chinese medicinal materials on all links of industry chain as follows:the medicinal herb growers never benefit from soaring price;the counterfeiters and forgers in midstream industry increase;the gross profit rate of Chinese medicine enterprises declines.In accordance with the risk arising from abnormal fluctuation in price of traditional Chinese medicinal materials,corresponding precautionary measures are put forward as follows:promote the quality of traditional Chinese medicinal materials through management of value chain;curtail the production and management cost of traditional Chinese medicinal materials through management of organization chain;stabilize price of traditional Chinese medicinal materials through management of information chain;reduce transaction cost of traditional Chinese medicinal materials through management of logistics chain.

Problems in the Development of Traditional Chinese Medicinal Materials Planting Industry in Shiyan City and Countermeasures

Through the analysis on the cultivation advantages and development problems of traditional Chinese medicinal planting industry in Shiyan City, Hubei Province, some measures were proposed to enlarge and enhance the traditional Chinese medicinal planting industry, namely, large-scale, standardized, market-oriented and regionalized planting, thereby making it the pillar industry for farmers to increase income.

Systems Theory-Driven Framework for AI Integration into the Holistic Material Basis Research of Traditional Chinese Medicine

This paper introduces a systems theory-driven framework to integration artificial intelligence(AI)into traditional Chinese medicine(TCM)research,enhancing the understanding of TCM’s holistic material basis while adhering to evidence-based principles.Utilizing the System Function Decoding Model(SFDM),the research progresses through define,quantify,infer,and validate phases to systematically explore TCM’s material basis.It employs a dual analytical approach that combines top-down,systems theory-guided perspectives with bottom-up,elements-structure-function methodologies,provides comprehensive insights into TCM’s holistic material basis.Moreover,the research examines AI’s role in quantitative assessment and predictive analysis of TCM’s material components,proposing two specific AIdriven technical applications.This interdisciplinary effort underscores AI’s potential to enhance our understanding of TCM’s holistic material basis and establishes a foundation for future research at the intersection of traditional wisdom and modern technology.

Study on Agricultural Intellectual Property Protection and High-Quality Development of Traditional Chinese Medicine of Ginseng

Agricultural intellectual property has the functions of carrying forward agricultural cultural heritage,encouraging agricultural scientific and technological innovation,cultivating the brand of agricultural products and so on. The protection and application of agricultural intellectual property rights can enhance the vitality,innovation and competitiveness of agricultural economy,and promote the strategy of high-quality agricultural development and rural revitalization. Ginseng is a traditional medicinal variety with superior characteristics in Northeast China,and it is one of the most famous " three treasures" in Northeast China. This paper introduces ginseng( Panax ginseng C. A. Mey.) and its medicinal value,analyzes the traditional knowledge,biological genetic resources,new plant varieties,patents,geographical indications,trademarks and other agricultural intellectual property resources of ginseng,studies the traditional Chinese medicine GAP certification and certification of " Three Agricultural Products" and the construction of the dominant area of agricultural product( Fusong ginseng) with Chinese characteristics,and explores the rural revitalization strategy and traditional Chinese medicine development strategy,ginseng agricultural intellectual property protection and high quality development strategy.

Distribution patterns and industry planning of commonly used traditional Chinese medicinal plants in China

Medicinal plants are the primary material basis for disease prevention and treatment in traditional Chinese medicine(TCM).The conservation and sustainable utilization of these medicinal plants is critical for the development of the TCM industry.However,wild medicinal plant resources have sharply declined in recent decades.To ameliorate the shortage of medicinal plant resources,it is essential to explore the development potential of the TCM industry in different geographical regions.For this purpose,we examined the spatial distribution of commonly used medicinal plants in China,the number of Chinese medicinal material markets,and the number of TCM decoction piece enterprises.Specifically,multispecies superimposition analysis and Thiessen polygons were used to reveal the optimal range for planting bulk medicinal plants and the ideal regions for building Chinese medicinal material markets,respectively.Furthermore,we quantitatively analyzed mismatches between the spatial distribution of commonly used medicinal plant richness,Chinese medicinal material markets,and TCM decoction piece enterprises.We found that the areas suitable for growing commonly used medicinal plants in China were mainly distributed in Hengduan Mountain,Nanling Mountain,Wuling Mountain,and Daba Mountain areas.The Thiessen polygon network based on Chinese medicinal material market localities showed there are currently fewer markets in southwestern,northwestern,and northeastern China than in central and southern China.TCM decoction piece enterprises are concentrated in a few provinces,such as Hebei and Jiangxi.We found that the distribution of commonly used medicinal plants,Chinese medicinal material markets and TCM decoction piece enterprises are mismatched in Henan,Shaanxi,Hunan,Hubei,Zhejiang,Fujian,Chongqing,and Xizang.We recommend strengthening development of the TCM industry in Henan,Hunan,Zhejiang,Shaanxi,Hubei,Chongqing,Fujian,and Xizang;building more Chinese medicinal material markets in southwestern,northwestern,and northeastern China;and establishing medicinal plant nurseries in resource-rich provinces to better protect and domesticate local medicinal plants.

Study and Countermeasures on Safety Control of Traditional Chinese Medicines Industry Chain

I'm very grateful to Chinese Pharmaceutical Association and DIA for their elaborate organization,so that we are able to participate in the Sino-Europe Symposium.Yesterday and today,several professors have talked about various aspects.It is true that the effectiveness of traditional Chinese medicine is important,and safety is equally important.For this reason,our laboratory works on the effective test,and at the same time,since 2001,we have been focusing on the safety of traditional Chinese medicines,especially the research on exogenous pollution.Today,I would like to share with you some of the quality control of the whole industry chain of traditional Chinese medicine and some of our thoughts.

Protection of Intellectual Property and Authenticity of Chinese Herbal Medicine Chrysanthemum morifolium

This paper first introduced Chrysanthemum morifolium Ramat. and its medicinal value. Then, it studied agricultural intellectual property resources such as geographical indications, trademarks, patents, new plant varieties, biological genetic resources, and traditional knowledge related to C. morifolium . Finally, it summarized poverty-stricken areas ecologically suitable for planting C. morifolium , analyzed the GAP certification of C. morifolium , pollution-free agricultural product certification, green food certification, and organic food certification, and discussed the strategies for C. morifolium intellectual property protection and authenticity protection in the context of TCM development strategy and rural revitalization strategy.

Quality 4.0 technologies to enhance traditional Chinese medicine for overcoming healthcare challenges during COVID-19

The Quality 4.0 concept is derived from the industrial fourth revolution,i.e.,Industry 4.0.Quality 4.0 is the future of quality,where new digital and disruptive technologies are used to maintain quality in organizations.It is also suitable for traditional Chinese medicine(TCM)to maintain quality.This quality revolution aims to improve industrial and service sectors’quality by incorporating emerging technologies to connect physical systems with the natural world.The proposed digital philosophy can update and enhance the entire TCM treatment methodology to become more effective and attractive in the current competitive structure of the pharmaceutical and clinical industries.Thus,in healthcare,this revolution empowers quality treatment during the COVID-19 pandemic.There is a major requirement in healthcare to maintain the quality of medical tools,equipment,and treatment processes during a pandemic.Digital technologies can widely be used to provide innovative products and services with excellent quality for TCM.In this paper,we discuss the significant role of Quality 4.0 and how it can be used to maintain healthcare quality and fulfill challenges during the pandemic.Additionally,we discuss 10 significant applications of Quality 4.0 in healthcare during the COVID-19 pandemic.These technologies will provide unique benefits to maintain the quality of TCM throughout the treatment process.With Quality 4.0,quality can be maintained using innovative and advanced digital technologies.

Gaps and feasibility of fixed-dose combination strategy in the development of modern Chinese medicine

isTraditional Chinese medicine(TCM)is a highly complex chemical substance system,which not only reflected in the complexity of the chemical components and their interrelationships,but also in the intricacy of the prescription’s connection with the human body.Component compatibility strategy has been proposed for developing modern TCM since 2005 and established comprehensive relevant technologies and research approaches.Moreover,to meet the safety and efficacy of current pharmaceuticals,research on fixed-dose combination drugs is directed by modern scientific theories,conforms to TCM compatibility principles and clarifies material basis and pharmacological mechanisms and component-effect correlations.This review summarized gaps and feasibility of fixed-dose combination strategy in the development of modern TCM research and assessed their advantages and disadvantages in light of contemporary drug combination research practices.

Bioactive constituents of animal-derived traditional Chinese medicinal materials for breast cancer:opportunities and challenges

Breast cancer is globally the most common invasive cancer in women and remains one of the leading causes of cancer-related deaths.Surgery,radiotherapy,chemotherapy,immunotherapy,and endocrine therapy are currently the main treatments for this cancer type.However,some breast cancer patients are prone to drug resistance related to chemotherapy or immunotherapy,resulting in limited treatment efficacy.Consequently,traditional Chinese medicinal materials(TCMMs)as natural products have become an attractive source of novel drugs.In this review,we summarized the current knowledge on the active components of animal-derived TCMMs,including Ophiocordyceps sinensis-derived cordycepin,the aqueous and ethanolic extracts of O.sinensis,norcantharidin(NCTD),Chansu,bee venom,deer antlers,Ostrea gigas,and scorpion venom,with reference to marked anti-breast cancer effects due to regulating cell cycle arrest,proliferation,apoptosis,metastasis,and drug resistance.In future studies,the underlying mechanisms for the antitumor effects of these components need to be further investigated by utilizing multi-omics technologies.Furthermore,large-scale clinical trials are necessary to validate the efficacy of bioactive constituents alone or in combination with chemotherapeutic drugs for breast cancer treatment.

中药有效成分结合骨组织工程材料用于骨修复

背景:如何修复骨缺损一直以来是临床难题,中药有效成分在骨修复方面具有良好的生物活性与治疗效果,将中药有效成分与组织工程材料相结合在骨修复领域具有广阔的前景。不同中药有效成分与支架的组合在作用关系方面具有相似之处。目的:搜集常见的中药有效成分与支架材料组合的案例,基于七情配伍的启发将组织工程支架与中药有效成分类比为产生配伍关系的两类中药,以二者的作用关系为纲进行归纳总结。方法:检索1998年1月至2024年1月Pub Med和中国知网数据库中发表的相关文献,英文检索词:“traditional Chinese medicine,Chinese medicine,traditional Chinese medicine monomers,bone defect,bone repair,bone tissue engineering,tissue engineering,scaffold”,中文检索词:“中药,中药有效成分,中药单体,骨组织工程,骨组织工程支架,支架,组织工程,骨缺损,骨修复”,最终纳入88篇文献进行综述分析。结果与结论:(1)组织工程支架材料与中药有效成分各自均在骨修复领域有广泛的运用,二者在成骨方面优势明显但仍有许多缺陷,许多研究致力于将二者制备成复合材料,希望通过二者间的相互作用发挥减毒增效作用。(2)一些药物与材料在成骨、抗菌、促血管生成方面能互相促进,增强原有的效果,受到传统方剂配伍观念的启发,文章将其归纳为“相须”关系,并举实例佐证。(3)一些药物能提高材料的强度,而某些材料能对负载于其上的药物实现缓释控释效果、增加载药量与稳定性,或是进行靶向递送,文章将这种单方面的提升效果归纳为“相使”关系。(4)一些中药与材料搭配使用能减少对方的毒副反应,文章将这种减毒关系归纳为“相畏相杀”。(5)文章得出了一个由七情配伍关系启发、基于作用关系分类的关于中药复合支架的全新视角,将中药传统观念引入组织工程领域,为后续复合支架的研究者提供新的研究思路,并在选材搭配方面提供一定的便利。

The History of Saffron in China:From Its Origin to Applications

Saffron(Stigma Croci)is an autumn-flowering perennial plant,and its use has a history of over 3500 years.Saffron has often been considered as the costliest medicinal plant,a premium spice,and the best dye with a golden yellowish color.Iran currently produces the finest quality saffron and dominates its global production(>90%).Other countries such as Australia,Canada,the USA,China,and some countries in Central Africa,produce saffron at a lower yield.In China,saffron is celebrated as“red gold”owing to the red stigmas of the flower and its price,which is comparable to the price of gold.Saffron has been one of the most attractive traditional Chinese medicine(TCM)herbs in the Zhong Guo Yao Dian(《中国药典》Chinese Pharmacopoeia)since its inclusion in the 2005 edition.The earliest use of saffron in TCM was recorded in the Ben Cao Shi Yi(《本草拾遗》Supplement to Materia Medica)written during the Tang dynasty(741 A.D.).However,saffron grown in inland China has been widely mistaken as originating from Tibet.This is because its Chinese name begins with“Xi”or“Zang,”which sounds similar to its Tibetan name(“Xi Zang”).In this review,we clarify the origin of saffron and its introduction to China and summarize its various applications.

中药资源化学学科引领中药资源全产业链循环利用与绿色发展的创新与实践

中药资源化学学科的概念、内涵与外延、目标与任务等的提出及建设发展已20年。回顾20年的建设发展历程,围绕中药资源的科学生产与有效利用不断探索与创新实践,理论内涵进一步丰富,研究模式进一步完善,技术体系进一步拓展,形成了系列研究成果并得到推广应用,服务于中药资源产业的高质量发展,为中药资源全产业链提质增效与绿色发展做出了应有的贡献。然而,随着我国中医药产业的快速增长和产业链的不断拓展延伸,中药农业与中药工业生产过程产生的废弃物及副产物与日俱增,造成的资源浪费和环境污染已成为行业发展面临的新的重大问题。以中药资源全产业链循环利用与低碳绿色发展的模式建立与实例分析,以及中药资源循环利用生态产业示范园区创建为主线,展示近些年来取得的阶段性成效,以期为中药资源产业由线性经济模式向循环经济模式的低碳绿色转型提供示范和参考,为中药资源利用效率提升和新质生产力创造提供借鉴,为推动中药资源产业领域经济社会发展的低碳绿色提供助力。

陕西省第四次全国中药资源普查对秦药产业高质量发展的启示

通过对第四次全国中药资源普查陕西省相关工作成果进行梳理,明确了陕西省中药资源种类与构成情况,根据区域生境特点和生态适宜性提出秦药的适宜生产区划;总结了中药资源普查成果在陕西省乡村振兴和富民强省、中药产业合理布局和生产规划、中医药事业高质量可持续发展等方面的作用;最终,从加强种子种苗标准化研究、培育优良秦药品种,积极发展林下经济、构建中药材生态种植体系,引导秦药生产向绿色高效方向发展、促进秦药提质增效3个方面展望了秦药产业未来发展面临的挑战,为进一步聚焦秦药大品种、打造秦药全产业链、促进秦药产业绿色可持续发展提供科学参考。

基于产教融合理念的中药制药校企联合课程设计

通过任务驱动的探究式实践,教学团队将课程设计时空从校内实验室拓展到企业实践平台,课程设计内容延伸至企业生产实际,有力促进了课程设计与产业技术发展的联系,学生学会从技术可行性与经济合理性两个方面树立中药制药工艺及车间工艺设计原则与思想,综合应用能力及实践创新水平得以提升,从而为中药制药专业创新应用型人才的培养提供了有力支撑。

双高建设背景下中医类专业产教融合培育模式的探索

百年大计,教育为本。中医类专业实践性和综合性都极强,产教融合培育模式是培育中医类人才、发展中医类专业的重要模式。基于此,以“双高”建设背景下中医类专业产教融合培育模式为切入点,从其现存问题、模式内涵和探索途径三方面探究双高背景下中医类专业产教融合培育模式,以期为各界针对双高背景下中医类专业产教融合培育模式的探索发展的理论研究和教学实践提供一定参考。

黑龙江省中药材产业高质量发展的现实困境与实现路径

中药材产业的高质量发展是中医药传承创新发展的基础,且对优化农业生产结构、拓宽农民增收渠道、推动乡村产业振兴、促进中医药事业发展等都具有重要意义。针对黑龙江省中药材产业发展面临的问题,提出需从强化种质创新及良种繁育、实现种源良种化,打造规范化生态种植示范区、实现种植生态化,加强初深加工能力建设、实现运营产业化,深化寒地龙药品牌培育、实现产品品牌化,加快现代流通体系建设、推动产业数字化,创新药旅融合发展模式、实现三产融合化等方面加快推进中药材产业高质量发展。

中医药产业技术创新联盟的构建动机及运行机制研究——以江西省为例

基于中医药在改善民生、转变经济发展方式、弘扬中华文化、建设生态文明等国家大局中日益凸显的作用,结合产业技术创新联盟在推动产业发展、突破关键共性技术这一显著特点,提出中医药产业技术创新联盟的内涵,分析联盟构建动机。以江西省为例,从全生命周期角度提出中医药产业技术创新联盟的运行机制,保障联盟的稳定发展。

中草药栽培与鉴定专业实践教学体系优化研究

本文从师资力量、教学平台、教学体系和教学考核4个方面为切入点,研究了中草药栽培与鉴定专业实践教学模式现状。提出提升师资力量,打造教学平台,构建教学体系,以及建立考核评价机制等优化措施,并探索构建凸显中药特色“一核心、两阶段、三单元、四确保”的实践教学体系,阐述其体系优化改革的实践与思考。以全方位、多角度促进学生综合素质的提高,为中医药发展培养高素质复合型中药农业人才奠定基础。